| 產品名稱 |
Arthrinium sp. |
| 商品貨號 |
B183290 |
| Strain Designations |
FA1744 |
| Application |
produces arthrinone produces terpestacin |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Type Strain |
no |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol® |
no |
| Medium |
ATCC® Medium 307: Cornmeal agar
|
| Growth Conditions |
Temperature: 24.0°C |
| Name of Depositor |
Bristol-Myers Res. Inst. |
| U.S. Patent Number |
|
| Isolation |
soil, Akiyoshidoh, Yamaguchi Pref., Japan |
| References |
Oka M, et al. Terpestacin, a new syncytium formation inhibitor from Arthrinium sp. J. Antibiot. 46: 367-373, 1993. PubMed: 8478254
. . J. Nat. Prod. 57: 1656-1660, 1994.
|
